| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927657 | American Heart Journal | 2016 | 25 Pages |
Abstract
Patients treated with novel drug-eluting stents in small-vessel lesions had higher adverse event rates than did patients who had no small-vessel treatment. Our data suggest that with current stents, a vessel diameter <2.50 mm is a suitable threshold to identify small target vessels.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Liefke C. MD, Marlies M. MD, Peter W. MD, PhD, Alexander R. MD, Marc MD, PhD, Marije M. PhD, Gerard C.M. MD, PhD, Martin G. MD, PhD, Carine J.M. PhD, Clemens MD, PhD,